Episode
New ADHD Med Launches October
- Published
- Jun 24, 2026
- Duration seconds
- 111
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/auckland-news-today-2-min-news-the-daily-news-now-7853371/episodes/new-adhd-med-launches-october/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/auckland-news-today-2-min-news-the-daily-news-now-7853371/new-adhd-med-launches-october.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Big news for ADHD patients in New Zealand: Pharmac is launching Rubifen LA, a new long-acting methylphenidate starting October 1st, to boost supply and expand treatment options. With strengths including a new 60mg dose, it joins seven other brands now available — helping ease ongoing shortages that’ve plagued the country since 2023. Originally slated for July, the delay gives suppliers more time, while also covering narcolepsy patients under existing practice. This move responds directly to patient stress and disruption, offering more stability and choice for those relying on these meds until at least 2026. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/6d1531719dfdb5f9